Accession Number:

ADA461363

Title:

Afghanistan: Narcotics and U.S. Policy

Descriptive Note:

Congressional rept.

Corporate Author:

LIBRARY OF CONGRESS WASHINGTON DC CONGRESSIONAL RESEARCH SERVICE

Personal Author(s):

Report Date:

2006-12-10

Pagination or Media Count:

50.0

Abstract:

Opium poppy cultivation and drug trafficking have become significant negative factors in Afghanistans fragile political and economic order over the last 25 years. In 2006, poppy cultivation and opium production reached record highs, in spite of ongoing efforts by the Afghan government, the United States, and their international partners to combat poppy cultivation and drug trafficking. Afghanistan is now the source of 92 of the world s illicit opium. U.N. officials estimate that in-country illicit revenue from the 2006 opium poppy crop will be over 3 billion, sustaining fears that Afghanistan s economic recovery continues to be underwritten by drug profits and that large sums are reaching criminals, corrupt officials, and extremists. Across Afghanistan, regional militia commanders, criminal organizations, and corrupt government officials have exploited opium production and drug trafficking as reliable sources of revenue and patronage, which has perpetuated the threat these groups pose to the countrys fragile internal security and the legitimacy of its embryonic democratic government. The trafficking of Afghan drugs also appears to provide financial and logistical support to a range of extremist groups that continue to operate in and around Afghanistan, including the resurgent remnants of the Taliban and some Al Qaeda operatives. Although coalition forces may be less frequently relying on figures involved with narcotics for intelligence and security support, many observers have warned that drug-related corruption among appointed and elected Afghan officials may create new political obstacles to further progress.

Subject Categories:

  • Government and Political Science
  • Sociology and Law
  • Pharmacology
  • Economics and Cost Analysis

Distribution Statement:

APPROVED FOR PUBLIC RELEASE